Special Access Program for drugs: Guidance document for industry and practitioners

This guidance document explains the regulatory information requirements and conditions for practitioners and manufacturers when drugs are requested through the Special Access Program (SAP). It explains SAP's mandate, intent and scope, and outlines the responsibilities of practitioners and manufacturers.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2023-12-29

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data